Leal Therapeutics announces USD30m Series A extension and initiates Phase 1b/2a clinical trial of LTX-001 in schizophrenia

Can-Fite reports preclinical data supporting Phase IIb pancreatic cancer study

Galmed reports positive preclinical results for Aramchol in prostate cancer

Azra AI and 4DMedical partner on lung health intelligence

AstraZeneca reports positive Phase III results for Tagrisso and Orpathys

HUTCHMED reports positive Phase III results for ORPATHYS and TAGRISSO combination

BioSapien nominated in 'Best Startup' category for 20th Prix Galien USA Awards

Phanes Therapeutics' Spevatamig receives US FDA Fast Track designation in advanced and metastatic biliary tract carcinoma

ArkBio's Ziresovir gains US FDA Phase II clinical trial approval

Rigel's VEPPANU (vepdegestrant) available for patients with ER+/HER2-, ESR1-mutated advanced or metastatic breast cancer

Innorna Nominated for 2026 Prix Galien USA Best Startup Award

Elephas Biosciences partners Neuberg Diagnostics

Pilot Project between BioCytics and LIDE Biotech

Pharming launches Joenja in Japan for APDS patients aged four and above

PTC to acquire BLA-stage ST-920 Fabry disease programme